Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Smith

Showing results (481-490 of 530) with videos related to

Pageof 53
Sort By:
Clinical and Translational Science|August 23, 2015
Practice-based Research Network Research Good Practices (PRGPs): Summary of RecommendationsRowena J Dolor, Kimberly Campbell-Voytal, Jeanette Daly, et al.
Cancer Cell|May 3, 2003
p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosisDaniele Bergamaschi, Milena Gasco, Louise Hiller, et al.
Frontiers in Immunology|December 19, 2022
Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseasesSaeedeh Ghorbanalipoor, Shirin Emtenani, Melissa Parker, et al.
British Journal of Haematology|May 22, 2020
Prognostic indices in diffuse large B-cell lymphoma in the rituximab era: an analysis of the UK National Cancer Research Institute R-CHOP 14 versus 21 phase 3 trialMary Gleeson, Nicholas Counsell, David Cunningham, et al.
Frontiers in Immunology|October 17, 2022
Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseasesSaeedeh Ghorbanalipoor, Shirin Emtenani, Melissa Parker, et al.
Cancers|July 2, 2021
An Evaluation of the Tolerability and Feasibility of Combining 5-Amino-Levulinic Acid (5-ALA) with BCNU Wafers in the Surgical Management of Primary GlioblastomaColin Watts, Keyoumars Ashkan, Michael D Jenkinson, et al.
The New England Journal of Medicine|June 23, 2016
Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's LymphomaPeter Johnson, Massimo Federico, Amy Kirkwood, et al.
British Journal of Haematology|August 2, 2016
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) in the management of primary mediastinal B-cell lymphoma: a subgroup analysis of the UK NCRI R-CHOP 14 versus 21 trialMary Gleeson, Eliza A Hawkes, David Cunningham, et al.
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|January 17, 2025
The "CUPCAKE" technique (coiled underlying pseudoaneurysm contained by a woven endobridge device) for treating intracranial aneurysms with atypical morphologyViktorija Vainauskaite, Yifan Ren, Mohamed Nasra, et al.
JAMA|May 12, 2017
Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non-Small Cell Lung Cancer: The SELECT-1 Randomized Clinical TrialPasi A Jänne, Michel M van den Heuvel, Fabrice Barlesi, et al.
Pageof 53

Showing results (481-490 of 530) with videos related to

Sort By:
Pageof 53
Clinical and Translational Science|August 23, 2015
Practice-based Research Network Research Good Practices (PRGPs): Summary of RecommendationsRowena J Dolor, Kimberly Campbell-Voytal, Jeanette Daly, et al.
Cancer Cell|May 3, 2003
p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosisDaniele Bergamaschi, Milena Gasco, Louise Hiller, et al.
Frontiers in Immunology|December 19, 2022
Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseasesSaeedeh Ghorbanalipoor, Shirin Emtenani, Melissa Parker, et al.
British Journal of Haematology|May 22, 2020
Prognostic indices in diffuse large B-cell lymphoma in the rituximab era: an analysis of the UK National Cancer Research Institute R-CHOP 14 versus 21 phase 3 trialMary Gleeson, Nicholas Counsell, David Cunningham, et al.
Frontiers in Immunology|October 17, 2022
Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseasesSaeedeh Ghorbanalipoor, Shirin Emtenani, Melissa Parker, et al.
Cancers|July 2, 2021
An Evaluation of the Tolerability and Feasibility of Combining 5-Amino-Levulinic Acid (5-ALA) with BCNU Wafers in the Surgical Management of Primary GlioblastomaColin Watts, Keyoumars Ashkan, Michael D Jenkinson, et al.
The New England Journal of Medicine|June 23, 2016
Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's LymphomaPeter Johnson, Massimo Federico, Amy Kirkwood, et al.
British Journal of Haematology|August 2, 2016
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) in the management of primary mediastinal B-cell lymphoma: a subgroup analysis of the UK NCRI R-CHOP 14 versus 21 trialMary Gleeson, Eliza A Hawkes, David Cunningham, et al.
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|January 17, 2025
The "CUPCAKE" technique (coiled underlying pseudoaneurysm contained by a woven endobridge device) for treating intracranial aneurysms with atypical morphologyViktorija Vainauskaite, Yifan Ren, Mohamed Nasra, et al.
JAMA|May 12, 2017
Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non-Small Cell Lung Cancer: The SELECT-1 Randomized Clinical TrialPasi A Jänne, Michel M van den Heuvel, Fabrice Barlesi, et al.
Pageof 53